Lipe & Dalton Baxter International Inc Transaction History

Lipe & Dalton

$185 Million
Q2 2025

A detailed history of Lipe & Dalton transactions in Baxter International Inc stock. As of the latest transaction made, Lipe & Dalton holds 11,835 shares of BAX stock, worth $271,849. This represents 0.19% of its overall portfolio holdings.

Number of Shares

11,835

Previous 11,835 -0.0%

Holding current value

$271,849

Previous $405,000 11.6%

% of portfolio

0.19%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$28.63 - $37.84 $27,055 - $35,758	-945 Reduced 7.39%	11,835 $345,000
Q2 2024 Aug 02, 2024	SELL	$32.87 - $43.55 $13,147 - $17,420	-400 Reduced 3.03%	12,780 $427,000
Q3 2023 Nov 03, 2023	SELL	$37.32 - $49.29 $13,995 - $18,483	-375 Reduced 2.77%	13,180 $497,000
Q2 2023 Jul 26, 2023	SELL	$39.98 - $47.68 $17,991 - $21,456	-450 Reduced 3.21%	13,555 $618,000
Q1 2023 May 02, 2023	SELL	$37.58 - $52.57 $437,807 - $612,440	-11,650 Reduced 45.41%	14,005 $568,000
Q4 2022 Feb 03, 2023	SELL	$49.7 - $57.71 $223,003 - $258,944	-4,487 Reduced 14.89%	25,655 $1.31 Million
Q3 2022 Nov 07, 2022	SELL	$53.86 - $66.8 $277,702 - $344,420	-5,156 Reduced 14.61%	30,142 $1.62 Million
Q2 2022 Aug 01, 2022	SELL	$63.83 - $80.0 $301,596 - $378,000	-4,725 Reduced 11.81%	35,298 $2.27 Million
Q1 2022 Apr 26, 2022	SELL	$76.85 - $89.45 $37,656 - $43,830	-490 Reduced 1.21%	40,023 $3.1 Million
Q4 2021 Feb 01, 2022	SELL	$74.57 - $87.19 $33,481 - $39,148	-449 Reduced 1.1%	40,513 $3.48 Million
Q3 2021 Nov 01, 2021	SELL	$73.77 - $83.61 $75,614 - $85,700	-1,025 Reduced 2.44%	40,962 $3.3 Million
Q2 2021 Aug 02, 2021	BUY	$80.5 - $88.01 $80 - $88	1 Added 0.0%	41,987 $3.38 Million
Q1 2021 Apr 30, 2021	SELL	$76.38 - $86.03 $42,009 - $47,316	-550 Reduced 1.29%	41,986 $3.54 Million
Q4 2020 Jan 29, 2021	SELL	$75.39 - $82.36 $26,386 - $28,826	-350 Reduced 0.82%	42,536 $3.41 Million
Q3 2020 Oct 30, 2020	SELL	$78.33 - $90.73 $29,295 - $33,933	-374 Reduced 0.86%	42,886 $3.45 Million
Q2 2020 Aug 07, 2020	SELL	$78.66 - $94.14 $29,497 - $35,302	-375 Reduced 0.86%	43,260 $3.73 Million
Q1 2020 May 01, 2020	SELL	$71.57 - $93.3 $96,547 - $125,861	-1,349 Reduced 3.0%	43,635 $3.54 Million
Q4 2019 Jan 21, 2020	SELL	$76.7 - $88.45 $34,515 - $39,802	-450 Reduced 0.99%	44,984 $3.76 Million
Q3 2019 Nov 07, 2019	SELL	$81.4 - $89.78 $303,215 - $334,430	-3,725 Reduced 7.58%	45,434 $3.97 Million
Q2 2019 Jul 24, 2019	SELL	$73.44 - $82.41 $25,630 - $28,761	-349 Reduced 0.7%	49,159 $4.03 Million
Q1 2019 Apr 30, 2019	SELL	$64.48 - $81.31 $80,600 - $101,637	-1,250 Reduced 2.46%	49,508 $4.03 Million
Q4 2018 Feb 08, 2019	SELL	$61.45 - $77.8 $20,401 - $25,829	-332 Reduced 0.65%	50,758 $3.34 Million
Q3 2018 Nov 05, 2018	SELL	$70.71 - $77.75 $44,193 - $48,593	-625 Reduced 1.21%	51,090 $3.94 Million
Q2 2018 Aug 06, 2018	SELL	$63.43 - $75.41 $23,786 - $28,278	-375 Reduced 0.72%	51,715 $3.82 Million
Q1 2018 May 04, 2018	SELL	$62.56 - $72.26 $180,360 - $208,325	-2,883 Reduced 5.24%	52,090 $3.39 Million
Q4 2017 Feb 13, 2018	SELL	$61.45 - $66.05 $524,168 - $563,406	-8,530 Reduced 13.43%	54,973 $3.55 Million
Q3 2017 Nov 03, 2017	SELL	$59.5 - $64.61 $985,915 - $1.07 Million	-16,570 Reduced 20.69%	63,503 $3.99 Million
Q2 2017 Aug 08, 2017	BUY	N/A	80,073	80,073 $4.85 Million

Others Institutions Holding BAX

# of Institutions

902

Shares Held

479M

Call Options Held

3.64M

Put Options Held

1.52M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $11.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account